| |
|
2009
R’million |
|
Restated
2008
R’million |
| 33. |
PROFIT FOR THE YEAR FROM DISCONTINUED OPERATIONS |
|
|
|
| |
On 31 May 2009 the Group disposed of its 50% shareholding in Astrix Laboratories Ltd. This joint venture is classified as a discontinued operation in the current year and the prior year has been restated accordingly. |
|
|
|
| |
Abridged income statement |
|
|
|
| |
Revenue |
286,1 |
|
198,8 |
| |
Profit before tax |
31,9 |
|
29,8 |
| |
Profit for the year |
10,9 |
|
19,7 |
| |
Abridged statement of cash flows |
|
|
|
| |
Net cash used from operating activities |
(8,1) |
|
(7,7) |
| |
Net cash used in investing activities |
(5,7) |
|
(11,4) |
| |
Net cash generated from financing activities |
24,3 |
|
25,9 |
| |
Movement in cash and cash equivalents before exchange rate changes |
10,5 |
|
6,8 |
| |
Effects of exchange rate changes |
(0,1) |
|
(0,7) |
| |
Cash and cash equivalents |
|
|
|
| |
Movement in cash and cash equivalents |
10,4 |
|
6,1 |
| |
Cash and cash equivalents at the beginning of the year |
(10,4) |
|
(16,5) |
| |
Cash and cash equivalents at the end of the year |
— |
|
(10,4) |
|
